Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Hogan Lovells Publications
29 June 2020
As we've previously reported in detail, on November 1, 2019, the U.S. Department of Education (ED) published final rules concerning state authorization of distance education programs and...
Hogan Lovells Publications
29 June 2020
The government has announced that on 4 July 2020, it will commence the third stage of its plan to ease the 'lockdown' restrictions implemented in England due to COVID-19. Following the re-op...
Hogan Lovells Publications
29 June 2020
New measures, announced on 21 June 2020, will allow the UK Government to intervene in relation to transactions involving businesses with "critical capabilities" to help combat public health ...
Insights
Registered Content
29 June 2020
The General Court ("GC") has annulled the EUIPO Board of Appeal (BOA) decision as it erred in the overall assessment of the evidence filed by Louis Vuitton ("LV")...
Hogan Lovells Publications
29 June 2020
Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting edge topics such as...
Hogan Lovells Publications
29 June 2020
At the moment Brexit appears to have been forgotten by many. This is understandable – the impact of COVID-19 is so immediate, vast and deep that the economic impact of Brexit seems...
News
29 June 2020
As of 23 June, the UK government can scrutinize certain foreign takeovers and other acquisitions to ensure that they do not jeopardize the UK's capability to combat, and mitigate the...
News
29 June 2020
Last week, on 23-25 June 2020, the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) updated the responses to six of the Frequently Asked Questions...
News
29 June 2020
Recent regulatory developments of interest to all financial institutions. Includes COVID-19 and Brexit-related updates, amendments to the list of high-risk third countries in MLD4, and...
